Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Olaparib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Olaparib in combination with Pembrolizumab in Participants with solid tumors Previously Treated
Phase: 2Phase II in Spain, 1Phase I